Human foetal brain tissue as quality control when developing stem cells towards cell replacement therapy for neurological diseases

NeuroReport

Volumn 24, Issue 18, 2013, Pages 1025-1030

  Nelander, Jenny ^a   Grealish, Shane ^a   Parmar, Malin ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Cell replacement therapy; Human foetal tissue; Huntington's disease; Neural progenitors; Neurological diseases; Parkinson's disease; Stem cells

Indexed keywords

BRAIN LIPID BINDING PROTEIN; CYCLOSPORIN A; LIPID BINDING PROTEIN; NEUROGENIN 2; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ARTICLE; BRAIN TISSUE; CELL LABELING; CELL MATURATION; CELL TRANSPLANTATION; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; EMBRYONIC STEM CELL; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GENE EXPRESSION; GLIA CELL; GRAFT SURVIVAL; HUMAN; HUMAN FETAL BRAIN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; INNERVATION; MESENCEPHALON; NEURAL STEM CELL; NONHUMAN; NUDE RAT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUALITY CONTROL; RODENT MODEL; SPECIES DIFFERENCE; SPRAGUE DAWLEY RAT; TREATMENT DURATION; VENTRAL MIDBRAIN; XENOTRANSPLANTATION;

BRAIN TISSUE TRANSPLANTATION; CELL- AND TISSUE-BASED THERAPY; EMBRYONIC STEM CELLS; FETAL TISSUE TRANSPLANTATION; HUMANS; NEURODEGENERATIVE DISEASES; QUALITY CONTROL;

EID: 84889254011     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0000000000000058     Document Type: Article

References (30)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282:1145-1147. (Pubitemid 28516247)
2. Kirkeby A, Grealish S, Wolf DA, Nelander J, Wood J, Lundblad M, et al. Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Rep 2012; 1:703-714.
3. Ma L, Hu B, Liu Y, Vermilyea SC, Liu H, Gao L, et al. Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acidlesioned mice. Cell Stem Cell 2012; 10:455-464.
4. Kriks S, Shim JW, Piao J, Ganat YM, Wakeman DR, Xie Z, et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 2011; 480:547-551.
5. Carri AD, Onorati M, Lelos MJ, Castiglioni V, Faedo A, Menon R, et al. Developmentally coordinated extrinsic signals drive human pluripotent stem cell differentiation toward authentic DARPP-32 + medium-sized spiny neurons. Development 2013; 140:301-312.
6. Maroof AM, Keros S, Tyson JA, Ying SW, Ganat YM, Merkle FT, et al. Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells. Cell Stem Cell 2013; 12: 559-572.
7. Liu Y, Liu H, Sauvey C, Yao L, Zarnowska ED, Zhang SC. Directed differentiation of forebrain GABA interneurons from human pluripotent stem cells. Nat Protoc 2013; 8:1670-1679.
8. Xi J, Liu Y, Liu H, Chen H, Emborg ME, Zhang SC. Specification of midbrain dopamine neurons from primate pluripotent stem cells. Stem Cells 2012; 30:1655-1663.
9. Wernig M, Zhao JP, Pruszak J, Hedlund E, Fu D, Soldner F, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci USA 2008; 105:5856-5861. (Pubitemid 351758462)
10. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126:663-676. (Pubitemid 44233629)
11. Kim J, Efe JA, Zhu S, Talantova M, Yuan X, Wang S, et al. Direct reprogramming of mouse fibroblasts to neural progenitors. Proc Natl Acad Sci USA 2011; 108:7838-7843.
12. Ring KL, Tong LM, Balestra ME, Javier R, Andrews-Zwilling Y, Li G, et al. Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor. Cell Stem Cell 2012; 11:100-109.
13. Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Sudhof TC, Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010; 463:1035-1041.
14. Pfisterer U, Kirkeby A, Torper O, Wood J, Nelander J, Dufour A, et al. Direct conversion of human fibroblasts to dopaminergic neurons. Proc Natl Acad Sci USA 2011; 108:10343-10348.
15. Lindvall O. Developing dopaminergic cell therapy for Parkinson's disease - give up or move forward? Mov Disord 2013; 28:268-273.
16. Benraiss A, Goldman SA. Cellular therapy and induced neuronal replacement for Huntington's disease. Neurotherapeutics 2011; 8:577-590.
17. Lindvall O, Brundin P, Widner H, Rehncrona S, Gustavii B, Frackowiak R, et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 1990; 247:574-577.
18. Barry DI, Wanscher B, Kragh J, Bolwig TG, Kokaia M, Brundin P, et al. Grafts of fetal locus coeruleus neurons in rat amygdala-piriform cortex suppress seizure development in hippocampal kindling. Exp Neurol 1989; 106:125-132. (Pubitemid 19279478)
19. Lindvall O, Widner H, Rehncrona S, Brundin P, Odin P, Gustavii B, et al. Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants. Ann Neurol 1992; 31:155-165.
20. Priller C, Bauer T, Mitteregger G, Krebs B, Kretzschmar HA, Herms J. Synapse formation and function is modulated by the amyloid precursor protein. J Neurosci 2006; 26:7212-7221.
21. Zhang XM, Cai Y, Xiong K, Cai H, Luo XG, Feng JC, et al. Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development. Eur J Neurosci 2009; 30:2271-2283.
22. Fougerousse F, Bullen P, Herasse M, Lindsay S, Richard I, Wilson D, et al. Human-mouse differences in the embryonic expression patterns of developmental control genes and disease genes. Hum Mol Genet 2000; 9:165-173. (Pubitemid 30052740)
23. Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol 2004; 172:2731-2738. (Pubitemid 38263654)
24. Nelander J, Hebsgaard JB, Parmar M. Organization of the human embryonic ventral mesencephalon. Gene Expr Patterns 2009; 9:555-561.
25. Hebsgaard JB, Nelander J, Sabelstrom H, Jonsson ME, Stott S, Parmar M. Dopamine neuron precursors within the developing human mesencephalon show radial glial characteristics. Glia 2009; 57:1648-1658.
26. Stromberg I, Adams C, Bygdeman M, Hoffer B, Boyson S, Humpel C. Longterm effects of human-to-rat mesencephalic xenografts on rotational behavior, striatal dopamine receptor binding, and mRNA levels. Brain Res Bull 1995; 38:221-233.
27. Belkadi AM, Geny C, Naimi S, Jeny R, Peschanski M, Riche D. Maturation of fetal human neural xenografts in the adult rat brain. Exp Neurol 1997; 144:369-380. (Pubitemid 27224564)
28. Brundin P, Nilsson OG, Strecker RE, Lindvall O, Astedt B, Bjorklund A. Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp Brain Res 1986; 65:235-240. (Pubitemid 17004013)
29. Rath A, Klein A, Papazoglou A, Pruszak J, Garcia J, Krause M, et al. Survival and functional restoration of human fetal ventral mesencephalon following transplantation in a rat model of Parkinson's disease. Cell Transplant 2013; 22:1281-1293.
30. Maria S, Helle B, Tristan L, Gaynor S, Arnar A, Michele M, et al. Improved cell therapy protocol for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC and non-human primate iPSC-derived DA neurons. Stem Cells 2013; 31:1548-1562.